2024 annual financial data
Fate Therapeutics 2024 Net margin
Direct answer
Net margin was -1,366.46%.
Operating income was -210,276,000 USD and net income was -186,262,000 USD.
Operating cash flow was -122,874,000 USD.
Get free Fate Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 13,631,000 USD
- Operating income
- -210,276,000 USD
- Net income
- -186,262,000 USD
- Operating cash flow
- -122,874,000 USD